Article

CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy

Topic: Business DevelopmentPublished January 17, 2024

Legacy signals

Legacy popularity: 288 legacy views

In the quest to develop safe and effective medicines, pharmaceutical companies rely on the precise combination of active pharmaceutical ingredients (APIs) and excipients. These crucial components play a pivotal role in the formulation of pharmaceutical drugs, ensuring optimal drug delivery and patient outcomes. Recently, CD Formulation released a comprehensive guide titled "Active Pharmaceutical Ingredients and Excipients Handbook" highlighting its latest advancements in this field. The handbook serves as a valuable resource for pharmaceutical scientists, formulators, and researchers, providing in-depth information about cutting-edge pharmaceutical ingredients and excipients. The featured APIs highlighted in the handbook are: β-Alanine (CAS 107-95-9), Heparin Sodium (CAS 9041-08-1), Vitamin C (CAS 50-81-7), Calcitriol, Vitamin D3 (CAS 67-97-0), and Montmorillonite (CAS 1318-93-0). In addition to APIs, the handbook emphasizes the critical role of excipients in drug formulation. Excipients are inactive components that facilitate the stability, bioavailability, and overall performance of the API. The handbook highlights various excipients, such as cellulose derivatives, polyethylene glycols, and sugar alcohols. Lactose Monohydrate and Starch are widely used as binders and disintegrants in tablet formulations, enhancing the tablet's mechanical strength and aiding in its disintegration for faster drug release and absorption. Thaumatin serves as a bulking agent and sweetener, contributing to the taste and mouthfeel of oral dosage forms. Polyoxyl 35 Castor Oil (CAS 61791-12-6) and Talc (CAS 14807-96-6) serve as stabilizers. “Overall, we hope this newly released handbook can serve as a useful guide for formulators and researchers, promoting their development of safe and effective pharmaceutical formulations. The comprehensive information on APIs and excipients empowers pharmaceutical scientists to optimize drug delivery systems, improve patient compliance, and enhance therapeutic outcomes,” said the Marketing Chief of CD Formulation. Please visit https://www.formulationbio.com/ to learn more.

Further reading

Further Reading

4 total

Article

Artificial intelligence continues to dominate business conversations, but enthusiasm alone does not guarantee results. While many companies rush to adopt AI in hopes of gaining a competitive edge, a large number of initiatives still fall short. The problem is rarely the technology itself. More often, failure happens because organizations approach AI without the structure, readiness, and discipline required for long-term success. AI projects do not fail because the technology

March 4, 2026

Article

AI Avatar Development: Real Innovation or Just Hype? In today’s hyperconnected world, attention is currency. To stand out, brands can no longer settle for flashy features or surface-level engagement. They need to build meaningful, scalable, and personalized experiences. Enter AI avatars: digital humans that are revolutionizing communication by bringing lifelike presence to virtual interactions. Imagine a team member who never takes a coffee break, speaks ten languages fluen

February 27, 2026

Article

The Quiet Engine Behind Every Connection Most people think of telecom services as towers, signals, and mobile data moving invisibly through the air. Yet behind every call that connects and every message that reaches its destination, there is another system quietly working in the background. That system is the call center. While customers often interact with telecom companies only when something goes wrong, these centers operate constantly, guiding problems toward solutions an

February 23, 2026

Article

Introduction The solar industry once believed that collecting as many leads as possible was the fastest path to growth. Marketing teams focused on filling databases with names, phone numbers, and email addresses. At first, the numbers looked promising. Dashboards showed rising interest and more inquiries than ever before. Yet behind the scenes, many companies began to notice a quiet problem. Revenue growth did not match the flood of leads. Sales teams felt overwhelmed, conver

February 6, 2026